Taline V. Khroyan - Concepedia

Author

Taline V. Khroyan

Also Known As

T V Khroyan, T. Khroyan, T. V. KHROYAN, T. V. Khroyan, T.V Khroyan, T.V. Khroyan, Taline Khroyan, Taline V Khroyan, Taline V. Khroyan

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

SRI International Menlo School Arizona State University Astraea Therapeutics (United States)Torrey Pines Institute For Molecular Studies

About

Taline V. Khroyan is an author at SRI International specializing in neuropharmacology, medicine, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	23	1.1K
2	Social Sciences	8	8	309
3	Health Sciences	7	7	370
4	Natural Sciences	3	3	84
5	Public Health	1	1	53

Taline V. Khroyan

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Dopamine D1- and D2-Like Receptor Mechanisms in Relapse to Cocaine-Seeking Behavior: Effects of Selective Antagonists and Agonists Taline V. Khroyan, Rita L. Barrett-Larimore, James K. Rowlett, Journal of Pharmacology and Experimental Therapeutics	2000	196
Dopamine receptor DRD2 genotype and smoking cessation outcome following treatment with bupropion SR Gary E. Swan, Ana M. Valdes, Huijun Z. Ring, The Pharmacogenomics Journal Functional SelectivityAddictionSmoking Cessation OutcomeNicotinePharmacology	2004	114
Hypocretin/orexin and nociceptin/orphanin FQ coordinately regulate analgesia in a mouse model of stress-induced analgesia Xinmin Xie, Jonathan P. Wisor, Junko Hara, Journal of Clinical Investigation Hcrt NeuronsAcute PainMolecular PainNociceptin/orphanin FqNeurochemistry	2008	107
Cyclooxygenase inhibition targets neurons to prevent early behavioural decline in Alzheimer’s disease model mice Nathaniel S. Woodling, Damien Colas, Qian Wang, Brain Synaptic TransmissionNeurochemical BiomarkersSpatial Memory DeficitsAlzheimer ’Synaptic Signaling	2016	105
Effects of intraaccumbens administration of SCH-23390 on cocaine-induced locomotion and conditioned place preference David L. Baker, Rita A. Fuchs, Sheila E. Specio, Synapse PsychopharmacologyPlace PreferenceCocaineExperimental PharmacologySocial Sciences	1998	100
Peptides derived from the prohormone proNPQ/spexin are potent central modulators of cardiovascular and renal function and nociception Lawrence Toll, Taline V. Khroyan, Kemal Sönmez, The FASEB Journal	2011	90
Comparison of the Antinociceptive and Antirewarding Profiles of Novel Bifunctional Nociceptin Receptor/μ-Opioid Receptor Ligands: Implications for Therapeutic Applications Lawrence Toll, Taline V. Khroyan, Willma E. Polgar, Journal of Pharmacology and Experimental Therapeutics	2009	82
Nociceptin/Orphanin FQ Receptor Activation Attenuates Antinociception Induced by Mixed Nociceptin/Orphanin FQ/μ-Opioid Receptor Agonists Taline V. Khroyan, Willma E. Polgar, Faming Jiang, Journal of Pharmacology and Experimental Therapeutics	2009	78
AT-1001: A High Affinity and Selective α3β4 Nicotinic Acetylcholine Receptor Antagonist Blocks Nicotine Self-Administration in Rats Lawrence Toll, Nurulain T. Zaveri, Willma E. Polgar, Neuropsychopharmacology Molecular PharmacologyMedicineNicotinePhysiologyNeuropharmacology	2012	74
Dose-dependent effects of the D3-preferring agonist 7-OH-DPAT on motor behaviors and place conditioning Taline V. Khroyan, David L. Baker, Janet L. Neisewander Psychopharmacology Place ConditioningKinesiologyBehavioral NeuroscienceDose-dependent EffectsPhysiology	1995	70

Page 1